Rentokil Initial shares jump as full-year targets maintained.


Shares in Rentokil Initial surged on Thursday after the pest control services group reassured investors by holding on to full-year guidance following two profit warnings earlier in the year, as it reported a steady third quarter with revenues unchanged.

Rentokil Initial

Source: Sharecast

Revenues in the three months to 30 September were flat on last year at £1.38bn, but would have been 3.6% higher at constant exchange rates.

On an organic basis, the top line improved by 2.6%, as strong performances in Europe (+4.7%), the UK and Sub-Saharan Africa (+4.2%) and Asia and MENAT (+6.5%) offset milder growth in North America (+1.4%) after a subdued summer.

The company said it still expects North American organic revenues to grow by just 1% in the second half, as it reiterated its target for adjusted profit before tax and amortisation £700m. This would represent a £66m decline from last year, and down from previous guidance of £750m.

The stock was up 9.1% at 372.19p by midday in London.

Commenting on the North American market, the company said: "After disappointing inbound digital lead flow in July and August, lead volume markedly improved in the second half of September. This was offset throughout Q3 by a slightly lower sales close rate and average dollar value for these leads."

The company said that actions in North America to increase organic growth and rebalance the cost base have been strengthened since the September trading update.

"In North America, we recognise the business has underperformed and we are focused on delivering the operational improvements required. We are expanding our initiatives to increase organic growth and we are taking action to mitigate cost overruns," said chief executive Andy Ransom.

Commenting on the statement, Russ Mould, investment director at AJ Bell, said while the share-price bounce will be "sweet relief for shareholders who have endured a tough period", actions to mitigate the weak performance in North America are only "baby steps".

"With a representative from Nelson Peltz’s Trian vehicle on the board, after the activist snapped up a stake in the company, pressure on its management is likely to remain acute. Chief executive Andy Ransom needs to deliver after more than a decade in situ," Mould said.


ISIN: GB00B082RF11
Exchange: London Stock Exchange
Sell:
349.70 p
Buy:
349.80 p
Change: 4.40 ( 1.27 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.